Literature DB >> 32787548

NaSH increases SIRT1 activity and autophagy flux through sulfhydration to protect SH-SY5Y cells induced by MPP~.

Jing Li1, Mei Li1, Cui Wang1, Shuhu Zhang1, Qiang Gao1, Liping Wang1, Lan Ma1.   

Abstract

Parkinson's disease (PD) is one of the most prevailing aging diseases around the world. The present study was to investigate the potential effect of hydrogen sulfide (H2S) and silent mating type information regulation 2 homolog 1 (SIRT1) in MPP~+ induced SH-SY5Y cells and its underlying mechanisms in PD. SH-SY5Y cells were induced by MPP~+ and treated with the H2S donor NaHS to detect the effect of H2S on the molecular behaviors of MPP~+ induced SH-SY5Y cells. NaHS reduced the apoptosis rate and expressions of MDA, 4-HNE and p62, while increased cell viability, autophagy flux and expressions of LC3 II/I and Beclin1 in MPP~+ induced SH-SY5Y cells. Then, levels of autophagy-related proteins and inflammation-related proteins (TNF-α, IL-Iβ) were detected, indicating that Chloroquine and Sirtinol reversed the protective effect of H2S on SH-SY5Y cells induced by MPP~+. We further explored the particular function of H2S, SH-SY5Y cells treated with MPP~+, NaHS chloroquine, and SIRT1 inhibitor (Sirtinol). The results showed that H2S increased SIRT1 expression and sulfhydration. Finally, a PD mouse model verified the above results. In a word, H2S ameliorated SIRT1 activity through acceleration of SIRT1 sulfhydration to increase the autophagy flux and attenuate damage of SH-SY5Y cells induced by MPP~+. H2S and SIRT1 activator might be a target in the treatment of PD patients.

Entities:  

Keywords:  Hydrogen sulfide; MPP~+; Parkinson’s disease; SH-SY5Y; SIRT1; autophagy flux

Year:  2020        PMID: 32787548      PMCID: PMC7513839          DOI: 10.1080/15384101.2020.1804179

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  39 in total

1.  Hydrogen Sulfide Attenuates Inflammatory Hepcidin by Reducing IL-6 Secretion and Promoting SIRT1-Mediated STAT3 Deacetylation.

Authors:  Hong Xin; Minjun Wang; Wenbo Tang; Zhuqing Shen; Lei Miao; Weijun Wu; Chengyi Li; Xiling Wang; Xiaoming Xin; Yi Zhun Zhu
Journal:  Antioxid Redox Signal       Date:  2015-09-03       Impact factor: 8.401

Review 2.  A meta-analytic review of prospection deficits in Parkinson's disease.

Authors:  Sarah P Coundouris; Gill Terrett; Liisa Laakso; Daniel Schweitzer; Anthony Kneebone; Peter G Rendell; Julie D Henry
Journal:  Neurosci Biobehav Rev       Date:  2019-11-01       Impact factor: 8.989

3.  miR-9-5p modulates the progression of Parkinson's disease by targeting SIRT1.

Authors:  Zuobo Wang; Lin Sun; Kaixue Jia; Hongxia Wang; Xiuxiang Wang
Journal:  Neurosci Lett       Date:  2019-02-28       Impact factor: 3.046

Review 4.  Synthesis and biological effects of hydrogen sulfide (H2S): development of H2S-releasing drugs as pharmaceuticals.

Authors:  Giuseppe Caliendo; Giuseppe Cirino; Vincenzo Santagada; John L Wallace
Journal:  J Med Chem       Date:  2010-09-09       Impact factor: 7.446

5.  Pancreatic cancers require autophagy for tumor growth.

Authors:  Shenghong Yang; Xiaoxu Wang; Gianmarco Contino; Marc Liesa; Ergun Sahin; Haoqiang Ying; Alexandra Bause; Yinghua Li; Jayne M Stommel; Giacomo Dell'antonio; Josef Mautner; Giovanni Tonon; Marcia Haigis; Orian S Shirihai; Claudio Doglioni; Nabeel Bardeesy; Alec C Kimmelman
Journal:  Genes Dev       Date:  2011-03-15       Impact factor: 11.361

6.  Hydrogen sulfide protects against apoptosis under oxidative stress through SIRT1 pathway in H9c2 cardiomyocytes.

Authors:  Dan Wu; Qingxun Hu; Xinhua Liu; Lilong Pan; Qinghui Xiong; Yi Zhun Zhu
Journal:  Nitric Oxide       Date:  2014-11-25       Impact factor: 4.427

7.  Controlled release of hydrogen sulfide significantly reduces ROS stress and increases dopamine levels in transgenic C. elegans.

Authors:  Rafat Ali; Hilal Ahmad Pal; Rohil Hameed; Aamir Nazir; Sandeep Verma
Journal:  Chem Commun (Camb)       Date:  2019-08-07       Impact factor: 6.222

8.  Chrysoeriol mediates mitochondrial protection via PI3K/Akt pathway in MPP+ treated SH-SY5Y cells.

Authors:  Tanapol Limboonreung; Patoomratana Tuchinda; Sukumal Chongthammakun
Journal:  Neurosci Lett       Date:  2019-10-14       Impact factor: 3.046

Review 9.  Brain SIRT1 Mediates Metabolic Homeostasis and Neuroprotection.

Authors:  Jing Xu; Charlie W Jackson; Nathalie Khoury; Iris Escobar; Miguel A Perez-Pinzon
Journal:  Front Endocrinol (Lausanne)       Date:  2018-11-23       Impact factor: 5.555

Review 10.  Current Progress of Mitochondrial Quality Control Pathways Underlying the Pathogenesis of Parkinson's Disease.

Authors:  Xue Jiang; Tao Jin; Haining Zhang; Jing Miao; Xiuzhen Zhao; Yana Su; Ying Zhang
Journal:  Oxid Med Cell Longev       Date:  2019-08-14       Impact factor: 6.543

View more
  2 in total

Review 1.  Deciphering therapeutic options for neurodegenerative diseases: insights from SIRT1.

Authors:  Ruike Wang; Yingying Wu; Rundong Liu; Mengchen Liu; Qiong Li; Yue Ba; Hui Huang
Journal:  J Mol Med (Berl)       Date:  2022-03-11       Impact factor: 4.599

Review 2.  Sirtuin Oxidative Post-translational Modifications.

Authors:  Kelsey S Kalous; Sarah L Wynia-Smith; Brian C Smith
Journal:  Front Physiol       Date:  2021-11-24       Impact factor: 4.566

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.